跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 69 条关于
“Limiris”
全部
69
临床试验
52
药物
0
机构
1
资讯
16
3个月前
Rossium Subsidiary Seeks Russian Registration for Second Canakinumab Biosimilar After Belarus Approval
去年
FDA Limits GSK's Xevudy Authorization Due to BA.2 Variant Concerns
15天前
Lumirix® (Ruxolitinib Phosphate Cream) Approved in China for Mild-to-Moderate Atopic Dermatitis
去年
EMA Recommends Lecanemab for Early Alzheimer's, Limits Use to Specific Genetic Profiles
去年
Simris Group ADC Partnership Falls Through as EU Partner Withdraws Following Strategic Review
去年
FDA Recalls Six Acne Products After Testing Reveals Benzene Contamination Above Safety Limits
去年
Delaware Judge Limits Liquidia's Patent Defense Strategies in UTC Lung Disease Drug Dispute
2个月前
Microvilli "Trapping" of PD-1 Limits Immunotherapy Efficacy, Engineered Antibody Offers New Solution
去年
Federal Circuit Ruling Limits Patent Protection for Machine Learning Applications, Highlights Trade Secret Alternative
去年
FDA Approves Expanded Label for Astellas' Izervay, Removing Dosing Duration Limits for Geographic Atrophy
第 1 页,共 2 页
上一页
下一页